日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Responsible Use of Artificial Intelligence to Improve Kidney Care: A Statement from the American Society of Nephrology

负责任地使用人工智能改善肾脏护理:美国肾脏病学会声明

Tangri, Navdeep; Cheungpasitporn, Wisit; Crittenden, Stanley D; Fornoni, Alessia; Peralta, Carmen A; Singh, Karandeep; Usvyat, Len A; Waterman, Amy D

Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy

非奈利酮在慢性肾病、2型糖尿病和肾切除史患者中的应用

Munoz Mendoza, Jair; Weir, Matthew R; Anker, Stefan D; Filippatos, Gerasimos; Rossing, Peter; Ahlers, Christiane; Brinker, Meike; Fatoba, Samuel T; Horvat-Broecker, Andrea; Rohwedder, Katja; Fornoni, Alessia

Metal-Coordinated His-Tag Functionalization of Polymeric Nanogels for Therapeutic Applications

金属配位组氨酸标签功能化修饰聚合物纳米凝胶用于治疗应用

Colli, Camillo; De Filippis, Andrea; Galbo, Gabriele; Kunkl, Martina; Ivanova, Julia; Fornoni, Susan; Spatz, Joachim P; Rosanò, Laura; Moscatelli, Davide; Tuosto, Loretta; Mauri, Emanuele

Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity

靶向SMPDL3B以减轻放射线和顺铂引起的肾毒性

Ahmad, Anis; Mallela, Shamroop Kumar; Ansari, Saba; Alnukhali, Mohammed; Merscher, Sandra; Mitrofanova, Alla; Zeidan, Youssef H; Pollack, Alan; Fornoni, Alessia; Marples, Brian

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome

从肾素-血管紧张素-醛固酮系统阻断到再生医学:阿尔波特综合征治疗策略的演变

Lo Re, Claudia; Kim, Jin-Ju; Fornoni, Alessia

Correction: From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome

更正:从 RAAS 阻断到再生医学:Alport 综合征治疗策略的演变

Lo Re, Claudia; Kim, Jin-Ju; Fornoni, Alessia

The enzyme SMPDL3b in podocytes decouples proteinuria from chronic kidney disease progression in experimental Alport Syndrome

足细胞中的SMPDL3b酶在实验性Alport综合征中使蛋白尿与慢性肾脏疾病进展脱钩

Mitrofanova, Alla; Fontanella, Antonio M; Molina, Judith; Zhang, Guanshi; Mallela, Shamroop K; Severino, Luisa Ulloa; Santos J, Javier Varona; Tolerico, Matthew; Njeim, Rachel; Issa, Wadih; Boulina, Maria; Carrazco, Arianna; Semenova, Veronika; Zuo, Yiqin; Ficarella, Maria; Kim, Jin Ju; Sloan, Alexis; Sharma, Kumar; Yuen, Darren A; Perin, Laura; Burke, George W; Fornoni, Alessia; Merscher, Sandra

Corrigendum to "Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome" eBioMedicine, Volume 63, January 2021, 103162

更正“盘状蛋白结构域受体 1 激活将细胞外基质与 Alport 综合征中的足细胞脂毒性联系起来” eBioMedicine,第 63 卷,2021 年 1 月,103162

Kim, Jin-Ju; David, Judith M; Wilbon, Sydney S; Santos, Javier V; Patel, Devang M; Ahmad, Anis; Mitrofanova, Alla; Liu, Xiaochen; Mallela, Shamroop K; Ducasa, Gloria M; Ge, Mengyuan; Sloan, Alexis J; Al-Ali, Hassan; Boulina, Marcia; Mendez, Armando J; Contreras, Gabriel N; Prunotto, Marco; Sohail, Anjum; Fridman, Rafael; Miner, Jeffrey H; Merscher, Sandra; Fornoni, Alessia

Modulation of the Apolipoprotein M/S1PR4 Pathway Reduces Podocyte Lipid Overload in Alport Syndrome via Distinct Autophagy and Efflux Mechanisms.

载脂蛋白 M/S1PR4 通路的调节通过独特的自噬和外排机制减少 Alport 综合征中的足细胞脂质过载。

Tolerico Matthew, Molina Judith, Insenga Arianna, Carrazco Arianna, Njeim Rachel, Sloan Alexis, Griswold Anthony, Kurano Makoto, Mendez Armando, Nathans Robin, Bolek Robin, Ettou Sandrine, Berasi Stephen, Fornoni Alessia, Merscher Sandra

DMX-200 in Patients With Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial

DMX-200治疗原发性局灶节段性肾小球硬化症患者:2期ACTION2试验结果

Heerspink, Hiddo J L; Fornoni, Alessia; Inker, Lesley A; Noronha, Irene L; Trimarchi, Hernán; Wong, Muh Geot; Smith, Alisha; Shepherd, Robert; White, Carl W; Fuller, David; Barratt, Jonathan